Abstract
Goals of the work
The aim of this paper was to develop, validate, and assess the reliability of a clinical index for assessing post-radiation dentition breakdown.
Materials and methods
An expert panel of four dentists with expertise in post-radiation patient care, oral radiology, and mineralized tissues reviewed a series of clinical photographs (n = 60) depicting a wide range of post-radiation lesions varying in size, severity, and location. Based on panel input related to lesion severity rankings and cut-points along a continuum of destruction, a semiquantitative, ordinal lesion scale was developed. A companion scale was developed to account for existing restorations. The index was then reviewed by a separate panel of dental clinician/researchers for confirmation of face and content validity and was refined based on their input. Following index approval by the expert and confirmatory panels, the index was evaluated for test–retest reliability by two educator/clinicians. After a brief calibration session, examiners reviewed and independently scored a second series of lesion images (n = 60). One week later, the same examiners independently scored the same images displayed in a different order. Inter- and intra-rater reliability and agreement were assessed (Spearman r and Kappa statistic).
Main results
Respective to sessions 1 and 2, inter-rater reliability values were r = 0.97 and r = 0.98, with Kappa values of κ = 0.93 and κ = 0.95. Respective intra-rater reliability and agreement values were 0.99 and 0.98 (rater 1), and 0.98 and 0.95 (rater 2).
Conclusions
A new index was developed and subsequently demonstrated face validity and excellent inter- and intra-rater reliability for potentially evaluating the severity of post-radiation dentition breakdown.
References
American Cancer Society (2007) What are the key statistics about oral cavity and oropharyngeal cancer? Available at http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_are_the_key_statistics_for_oral_cavity_and_oropharyngeal_cancer_60.asp?rnav = cri
American Cancer Society (2007) Oral Cancer. Available at www.cancer.org/downloads/PRO/OralCancer.pdf
Anne PR, Curran WJ Jr (2002) A phase II trial of subcutaneous amifostine and radiation therapy in patients with head and neck cancer. Semin Radiat Oncol 12:18–19
Anneroth G, Holm LE, Karlsson G (1985) The effect of radiation on teeth. A clinical, histologic and microradiographic study. Int J Oral Surg 14:269–274
Beumer J, Curtis TA, Nishimura R (1996) Prosthodontic procedures: complete dentures. In: Beumer J, Curtis TA, Marunick MT (eds) Maxillofacial rehabilitation: prosthodontic and surgical considerations. Ishiyaku EuroAmerica, Inc, St. Louis, pp 101–102
Beumer J, Curtis TA, Nishimura R (1996) Preradiation extractions: current philosophies and literature review. In: Beumer J, Curtis TA, Marunick MT (eds) Maxillofacial rehabilitation: prosthodontic and surgical considerations. Ishiyaku EuroAmerica, Inc, St. Louis, pp 74–78
Bhaskar SN (1991) Salivary glands. Orban’s oral histology and embryology, 11th edn. Mosby-Year Book, Inc, St Louis, pp 337–371
Blanco AI, Chao KS, El Naqa I et al (2005) Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy. Int J Radiat Oncol Biol Phys 62:1055–1069
Bourhis J, De Crevoisier R, Abdulkarim B et al (2000) A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 46:1105–1108
Brizel DM, Wasserman TH, Henke M et al (2000) Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 18:3339–3345
Buentzel J, Micke O, Adamietz IA, Monnier A, Glatzel M, de Vries A (2006) Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III study. Int J Radiat Oncol Biol Phys 64:684–691
Chao KS, Deasy JO, Markman J et al (2001) A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 49:907–916
Chao KS (2002) Protection of salivary function by intensity-modulated radiation therapy in patients with head and neck cancer. Semin Radiat Oncol 12(1 Suppl 1):20–25
Eisbruch A, Ship JA, Dawson LA et al (2003) Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer. World J Surg 27:832–837
Frank RM, Herdly J, Philippe E (1965) Acquired dental defects and salivary gland lesions after irradiation for carcinoma. J Am Dent Assoc 70:868–883
Garden AS, Lewin JS, Chambers MS (2006) How to reduce radiation-related toxicity in patients with cancer of the head and neck. Curr Oncol Rep 8:140–145
Jansma J, Vissink A, Jongebloed WL, Retief DH, Johannes’s-Gravenmade E (1993) Natural and induced radiation caries: a SEM study. Am J Dent 6:130–136
Jongebloed WL, Gravenmade EJ, Retief DH (1988) Radiation caries. A review and SEM study. Am J Dent 1:139–146
Kahn ST, Johnstone PA (2005) Management of xerostomia related to radiotherapy for head and neck cancer. Oncology (Williston Park) 19:1827–1832, (discussion 1832–1824, 1837–1829)
Karmiol M, Walsh RF (1975) Dental caries after radiotherapy of the oral regions. J Am Dent Assoc 91:838–845
Kielbassa AM, Hinkelbein W, Hellwig E, Meyer-Luckel H (2006) Radiation-related damage to dentition. Lancet Oncol 7:326–335
Koukourakis MI, Kyrias G, Kakolyris S et al (2000) Subcutaneous administration of amifostine during fractionated radiotherapy: a randomized phase II study. J Clin Oncol 18:2226–2233
Lacatusu S, Francu L, Francu D (1996) Clinical and therapeutical aspects of rampant caries in cervico-facial irradiated patients. Rev Med Chir Soc Med Nat Iasi 100:198–202
Marx RE, Stern D (2002) Radiation caries. In: Oral and maxillofacial pathology: a rationale for diagnosis and treatment. Quintessence Co, Inc, Chicago, pp 380–381
Oral Cancer Foundation (2007) Oral cancer facts. Available at http://www.oralcancerfoundation.org/facts/index.htm
Ord RA, Blanchaert RH Jr (2001) Current management of oral cancer. A multidisciplinary approach. J Am Dent Assoc 132(Suppl):19S–23S
Rosenthal DI, Chambers MS, Weber RS, Eisbruch A (2004) A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing. Semin Oncol 31:25–28
Ship JA, Hu K (2004) Radiotherapy-induced salivary dysfunction. Semin Oncol 31:29–36
Vacha P, Fehlauer F, Mahlmann B et al (2003) Randomized phase III trial of postoperative radiochemotherapy +/− amifostine in head and neck cancer. Is there evidence for radioprotection. Strahlenther Onkol 179:385–389
Vissink A, Jansma J, Spijkervet FK, Burlage FR, Coppes RP (2003) Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med 14:199–212
Wagner W, Prott FJ, Schonekas KG (1998) Amifostine: a radioprotector in locally advanced head and neck tumors. Oncol Rep 5:1255–1257
WorldHealthOrganization (2007) Caries Prevalence: DMFT and DMFS. Available at http://www.whocollab.od.mah.se/index.html
Acknowledgments
This study was supported by the National Institutes of Health/National Institute of Dental Craniofacial Research Grant K23 DE01623. The authors thank Paulette Spencer, Brenda Bohaty, Christos Angelopoulos, Nadeem Dallal, Chris Rice, Mary Lynn Froeschle, Kathy Dockter, and Susan McMillen for their assistance with this project.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Walker, M.P., Williams, K.B. & Wichman, B. Post-radiation dental index: development and reliability. Support Care Cancer 16, 525–530 (2008). https://doi.org/10.1007/s00520-007-0393-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-007-0393-x